 CAMBRIDGE, Mass., Aug. 11, 2021 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported recent business highlights and second quarter 2021 financial results. 